IL-33: a promising therapeutic target for rheumatoid arthritis?

By Yuan Feng-Lai   Li Xia   Lu Wei-Guo   Li Cheng-Wan   Xu Rui-Sheng   Dong Jian  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 529-534

Informa Healthcare

Access to resources Recommend Favorite

Serial determination of serum IL‐6, TNF‐α, and IL‐17 in a patient with rheumatoid arthritis successfully treated with kampo medicine: Case report and literature review

By  

Traditional & Kampo Medicine, Vol. 3, Iss. 1, 2016-04 ,pp. : 75-78

John Wiley & Sons Inc

Access to resources Recommend Favorite

IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis

By Gabay C.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 113-127

Informa Healthcare

Access to resources Recommend Favorite

Signal Transduction by IL-2 and its Receptors as Target in Treatment of Rheumatoid Arthritis

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-01 ,pp. : 41-50

Bentham Science Publishers

Access to resources Recommend Favorite

Sex Influences on the Penetrance of IL-1β and IL-1RN Genotypes for Rheumatoid Arthritis in the Chinese Population

By You C-G   Yin Y-S   Xie X-D   Ju J   Wang Z-P   Chen Y-R  

The Journal of International Medical Research, Vol. 35, Iss. 3, 2007-05 ,pp. : 323-328

Field House Publishing

Access to resources Recommend Favorite